Stay updated on Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government funding notice and current operating status information with links; updated version to v3.2.0. - Removed the Huntington disease resource and the previous version tag v3.1.0.SummaryDifference4%
- Check17 days agoChange DetectedCore content updates with a new version (v3.1.0) and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older version (v3.0.2).SummaryDifference0.4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations related to Huntington's disease and drug safety, while removing previous location details and references to Huntington Disease.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability WVE-120102 in Huntington's Disease Clinical Trial page.